Added to YB: 2025-10-21
Pitch date: 2025-10-20
SIGA [neutral]
SIGA Technologies, Inc.
-48.54%
current return
Author Info
Contrarian Cashflows publishes a monthly deep dive on a new value stock. Sign up for the newsletter.
Company Info
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States.
Market Cap
$276.9M
Pitch Price
$7.50
Price Target
N/A
Dividend
15.54%
EV/EBITDA
6.05
P/E
13.79
EV/Sales
1.41
Sector
Pharmaceuticals
Category
special_situation
Monday Delight: 20/10/25 - SIGA Technologies, Inc.
SIGA (quick overview): Biotech focused on antiviral therapeutics & biodefense, notably TPOXX for smallpox. 48% ROIC, 4.1x EV/EBIT, $593M mkt cap. Majority revenue from US gov contract expiring Q4 2025 - renewal uncertain amid healthcare spending debates. Event-driven opportunity for investors with strong Washington political/budget views.
Read full article (1 min)